US equities
|
MU
$904.90
▲+2.97%
NVDA
$217.09
▲+1.38%
AMZN
$262.45
▲+4.98%
TSLA
$368.06
▲+3.76%
AAPL
$342.94
▼-0.15%
SNDK
$1,371.12
▲+5.53%
META
$705.44
▼-0.55%
SPCX
$147.96
▲+1.32%
MU
$904.90
▲+2.97%
NVDA
$217.09
▲+1.38%
AMZN
$262.45
▲+4.98%
TSLA
$368.06
▲+3.76%
AAPL
$342.94
▼-0.15%
SNDK
$1,371.12
▲+5.53%
META
$705.44
▼-0.55%
SPCX
$147.96
▲+1.32%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about Als
Recent news which mentions Als
This Medical Stock Soared Over 80% In Pre-Market After Advancing Gene Therapy Program For ALS, Alzheimer's And Parkinson's Diseases
July 09, 2024
Tickers
ALS
NEWS
WENA
Tags
Pooja Rajkumari
gene therapy
Pre/Market Outlook
From
Benzinga
5 Biotech Stocks That Could Soar Thanks To These Disruptive Healthcare Technologies
June 20, 2023
Tickers
ALS
ALT
BIIB
CYTK
Tags
Biotech
healthcare
Tech
From
Benzinga
Blue Heart Records announces posthumous album from Willie J. Campbell
May 04, 2023
Tickers
ALS
Tags
Music
The Proven Ones
Health
From
PRLog
Canada Approves Amylyx's ALS Drug; FDA To Consider Approval In September
June 13, 2022
Tickers
ALS
AMLX
Tags
Amylyx Pharmaceuticals
Health Canada
Market News
From
Benzinga
FDA Approves PharmaTher's Phase 2 Trial For Ketamine ALS Treatment
January 12, 2022
Tickers
ALS
PHRRF
Tags
ALS
Regulations
Cannabis
From
Benzinga